C(OC([NH:8][C@H:9]([C:11]1[N:12]([C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[C:13]2[C:19]([CH2:20][O:21]C(=O)C)=[C:18]([F:25])[CH:17]=[CH:16][C:14]=2[N:15]=1)[CH3:10])=O)(C)(C)C.[ClH:32]>CO.O1CCOCC1>[ClH:32].[ClH:32].[NH2:8][C@H:9]([C:11]1[N:12]([C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[C:13]2[C:19]([CH2:20][OH:21])=[C:18]([F:25])[CH:17]=[CH:16][C:14]=2[N:15]=1)[CH3:10]To a solution of acetic acid 2-((S)-1-tert-butoxycarbonylaminoethyl)-5-fluoro-3-phenyl-3H-benzoimidazol-4-ylmethyl ester (190 mg, 0.44 mmol) in methanol (2 mL) was added HCl in dioxane (4N, 5 mL) and the reaction stirred at RT for 2 h. The reaction mixture was concentrated in vacuo to give the title compound as a beige solid (159 mg, 100%). LCMS (Method C): RT=1.61 min, [M+H]+=372.